Type 2 & other diabetes

Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

The Ahlqvist clustering architecture could be approximated in this Mediterranean cohort at diagnosis, but internal stability of the five-cluster solution was limited. In this population, a four-cluster structure showed substantially better internal validity. These findings support the feasibility of phenotypic subclassification of T2D while underscoring the importance of evaluating population-specific cluster structures and their clinical relevance in longitudinal studies.

Study context

Population
Adults with newly diagnosed T2D, Catalonia (Northeast Spain), recruited March 2022–January 2026
Participants
67 / 326 / 241 / 206 / 151 / 347 / 186 / 391
Exposure
Ahlqvist clustering vs data-driven clustering
  • Severe autoimmune diabetes (SAID)n = 67
  • Mild age-related diabetes (MARD)n = 326
  • Severe insulin-resistant diabetes (SIRD)n = 241
  • MODn = 206
  • Severe insulin-deficient diabetes (SIDD)n = 151
  • C1n = 347
  • C2n = 186
  • C3n = 391
Outcome
Cluster structure and stability
Follow-up
Diagnosis (baseline)
Methodological detailssex-stratified k-means clustering (k = 4), principal component analysis and silhouette analyses
  • Sex-stratified k-means clustering (k = 4)
  • Principal component analysis and silhouette analyses

Main finding

As reported in the abstract

diagnosis (baseline)

SAID

6.8%

67

Ahlqvist clusters: separation modest, bootstrap stability limited (Jaccard)
0.555-0.718
Unconstrained analysis: three clusters most internally optimal; stability substantially higher (Jaccard)
0.799-0.863
Concordance between Ahlqvist and data-driven models moderate (ARI)
0.473

Observational data: associations, not effects.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort. Cardiovasc Diabetol. Published 4 May 2026. doi:10.1186/s12933-026-03198-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.